Abstract
Bone grafting procedures are frequently performed for spinal applications in an attempt to promote successful arthrodesis. Autograft remains the gold standard grafting material. However, due to relatively limited supply and the morbidity associated with procurement of autograft, there has been a great deal of interest in developing alternative bone graft materials. Allograft and ceramic preparations are osteoconductive matrices that support bone formation, but these materials exhibit minimal osteoinductive potential. Recent research efforts have focused specifi cally on osteoinductive substances such as demineralized bone matrices, recombinant human bone morphogenetic proteins and autologous bone marrow aspirates. Since none of these materials deliver all of the elements required for bone formation when implanted alone, composite grafts, consisting of osteoinductive factors combined with an osteoconductive carrier, may prove to be more effective in stimulating spinal fusion than any single graft substitute.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
1. Vaccaro AR, Anderson DG, Patel T, et al. Comparison of OP-1 Putty (rhBMP-7) to iliac crest autograft for posterolateral lumbar arthrodesis: a minimum 2-year follow-up pilot study. Spine 2005;30:2709–16.
2. Vaccaro AR, Patel T, Fischgrund J, et al. A pilot study evaluating the safety and efficacy of OP-1 Putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis. Spine 2004;29:1885–92.
3. Zdeblick TA. A prospective, randomized study of lumbar fusion. Preliminary results. Spine 1993;18:983–91.
4. Chen WJ, Tsai TT, Chen LH, et al. The fusion rate of calcium sulfate with local autograft bone compared with autologous iliac bone graft for instrumented short-segment spinal fusion. Spine 2005;30:2293–7.
5. Sandhu HS, Grewal HS, Parvataneni H. Bone grafting for spinal fusion. Orthop Clin North Am 1999;30:685–98.
6. Madan SS, Harley JM, Boeree NR. Anterior lumbar interbody fusion: does stable anterior fixation matter? Eur Spine J 2003;12:386–92.
7. Mutoh N, Shinomiya K, Furuya K, et al. Pseudarthrosis and delayed union after anterior cervical fusion. Int Orthop 1993;17:286–9.
8. Gore DR, Sepic SB. Anterior cervical fusion for degenerated or protruded discs. A review of one hundred forty-six patients. Spine 1984;9:667–71.
9. Samartzis D, Shen FH, Lyon C, et al. Does rigid instrumentation increase the fusion rate in one-level anterior cervical discectomy and fusion? Spine J 2004;4:636–43.
10. Connolly PJ, Esses SI, Kostuik JP. Anterior cervical fusion: outcome analysis of patients fused with and without anterior cervical plates. J Spinal Disord 1996;9:202–6.
Urist M. Bone and Bone Transplants. Philadelphia: WB Saunders, 1980.
12. Brown CW, Orme TJ, Richardson HD. The rate of pseudarthrosis (surgical nonunion) in patients who are smokers and patients who are nonsmokers: a comparison study. Spine 1986;11:942–3.
13. Hollo I, Gergely I, Boross M. Smoking results in calcitonin resistance. JAMA 1977;237:2470.
14. Kwiatkowski TC, Hanley EN, Jr., Ramp WK. Cigarette smoking and its orthopedic consequences. Am J Orthop 1996;25:590–7.
de Vernejoul MC, Bielakoff J, Herve M, et al. Evidence for defective osteoblastic function. A role for alcohol and tobacco consumption in osteoporosis in middle-aged men. Clin Orthop Relat Res 1983:107–15.
Nilsson OS, Bauer HC, Brosjo O, et al. Influence of indomethacin on induced het-erotopic bone formation in rats. Importance of length of treatment and of age. Clin Orthop Relat Res 1986:239–45.
17. Deguchi M, Rapoff AJ, Zdeblick TA. Posterolateral fusion for isthmic spondy-lolisthesis in adults: analysis of fusion rate and clinical results. J Spinal Disord 1998;11:459–64.
18. Einhorn TA, Bonnarens F, Burstein AH. The contributions of dietary protein and mineral to the healing of experimental fractures. A biomechanical study. J Bone Joint Surg Am 1986;68:1389–95.
19. Arrington ED, Smith WJ, Chambers HG, et al. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res 1996;329:300–9.
20. Banwart JC, Asher MA, Hassanein RS. Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. Spine 1995;20:1055–60.
Prolo DJ, Rodrigo JJ. Contemporary bone graft physiology and surgery. Clin Orthop Relat Res 1985:322–42.
22. Stevenson S, Li XQ, Martin B. The fate of cancellous and cortical bone after transplantation of fresh and frozen tissue-antigen-matched and mismatched osteochon-dral allografts in dogs. J Bone Joint Surg Am 1991;73:1143–56.
23. Hamer AJ, Strachan JR, Black MM, et al. Biochemical properties of cortical allo-graft bone using a new method of bone strength measurement. A comparison of fresh, fresh-frozen and irradiated bone. J Bone Joint Surg Br 1996;78:363–8.
24. Pelker RR, Friedlaender GE, Markham TC. Biomechanical properties of bone allografts. Clin Orthop Relat Res 1983;174:54–7.
25. Jorgenson SS, Lowe TG, France J, et al. A prospective analysis of autograft versus allograft in posterolateral lumbar fusion in the same patient. A minimum of 1-year follow-up in 144 patients. Spine 1994;19:2048–53.
26. Nugent PJ, Dawson EG. Intertransverse process lumbar arthrodesis with allogeneic fresh-frozen bone graft. Clin Orthop Relat Res 1993;287:107–11.
27. Blanco JS, Sears CJ. Allograft bone use during instrumentation and fusion in the treatment of adolescent idiopathic scoliosis. Spine 1997;22:1338–42.
28. Dodd CA, Fergusson CM, Freedman L, et al. Allograft versus autograft bone in scoliosis surgery. J Bone Joint Surg Br 1988;70:431–4.
29. Jones KC, Andrish J, Kuivila T, et al. Radiographic outcomes using freeze-dried cancellous allograft bone for posterior spinal fusion in pediatric idiopathic scolio-sis. J Pediatr Orthop 2002;22:285–9.
30. Malloy KM, Hilibrand AS. Autograft versus allograft in degenerative cervical disease. Clin Orthop Relat Res 2002;394:27–38.
31. Vaccaro AR, Chiba K, Heller JG, et al. Bone grafting alternatives in spinal surgery. Spine J 2002;2:206–15.
32. Bucholz RW, Carlton A, Holmes RE. Hydroxyapatite and tricalcium phosphate bone graft substitutes. Orthop Clin North Am 1987;18:323–34.
33. Damien CJ, Parsons JR, Prewett AB, et al. Effect of demineralized bone matrix on bone growth within a porous HA material: a histologic and histometric study. J Biomater Appl 1995;9:275–88.
34. Kania RE, Meunier A, Hamadouche M, et al. Addition of fibrin sealant to ceramic promotes bone repair: long-term study in rabbit femoral defect model. J Biomed Mater Res 1998;43:38–45.
35. Frenkel SR, Moskovich R, Spivak J, et al. Demineralized bone matrix. Enhancement of spinal fusion. Spine 1993;18:1634–9.
36. Martin GJ, Jr., Boden SD, Titus L, et al. New formulations of demineralized bone matrix as a more effective graft alternative in experimental posterolateral lumbar spine arthrodesis. Spine 1999;24:637–45.
37. Morone MA, Boden SD. Experimental posterolateral lumbar spinal fusion with a demineralized bone matrix gel. Spine 1998;23:159–67.
38. An HS, Simpson JM, Glover JM, et al. Comparison between allograft plus dem-ineralized bone matrix versus autograft in anterior cervical fusion. A prospective multicenter study. Spine 1995;20:2211–6.
39. Thalgott JS, Giuffre JM, Klezl Z, et al. Anterior lumbar interbody fusion with titanium mesh cages, coralline hydroxyapatite, and demineralized bone matrix as part of a circumferential fusion. Spine J 2002;2:63–9.
40. Peterson B, Whang PG, Iglesias R, et al. Osteoinductivity of commercially available demineralized bone matrix. Preparations in a spine fusion model. J Bone Joint Surg Am 2004;86-A:2243–50.
41. Lee YP, Jo M, Luna M, et al. The efficacy of different commercially available dem-ineralized bone matrix substances in an athymic rat model. J Spinal Disord Tech 2005;18:439–44.
42. Friedlaender GE, Perry CR, Cole JD, et al. Osteogenic protein-1 (bone morpho-genetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 2001;83-A Suppl 1:S151–8.
43. Govender S, Csimma C, Genant HK, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002;84-A:2123–34.
44. Burkus JK, Gornet MF, Dickman CA, et al. Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 2002;15:337–49.
45. Grauer JN, Patel TC, Erulkar JS, et al. 2000 Young Investigator Research Award winner. Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion. Spine 2001;26:127–33.
46. Patel TC, Erulkar JS, Grauer JN, et al. Osteogenic protein-1 overcomes the inhibitory effect of nicotine on posterolateral lumbar fusion. Spine 2001;26:1656–61.
47. Cunningham BW, Shimamoto N, Sefter JC, et al. Osseointegration of autograft versus osteogenic protein-1 in posterolateral spinal arthrodesis: emphasis on the comparative mechanisms of bone induction. Spine J 2002;2:11–24.
48. Blattert TR, Delling G, Dalal PS, et al. Successful transpedicular lumbar interbody fusion by means of a composite of osteogenic protein-1 (rhBMP-7) and hydroxya-patite carrier: a comparison with autograft and hydroxyapatite in the sheep spine. Spine 2002;27:2697–705.
49. Boden SD, Martin GJ, Jr., Horton WC, et al. Laparoscopic anterior spinal arthro-desis with rhBMP-2 in a titanium interbody threaded cage. J Spinal Disord 1998;11:95–101.
50. Sandhu HS, Toth JM, Diwan AD, et al. Histologic evaluation of the efficacy of rhBMP-2 compared with autograft bone in sheep spinal anterior interbody fusion. Spine 2002;27:567–75.
51. Sandhu HS, Kanim LE, Kabo JM, et al. Evaluation of rhBMP-2 with an OPLA carrier in a canine posterolateral (transverse process) spinal fusion model. Spine 1995;20:2669–82.
52. Boden SD, Kang J, Sandhu H, et al. Use of recombinant human bone morphoge-netic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine 2002;27:2662–73.
53. Helm GA, Alden TD, Beres EJ, et al. Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent. J Neurosurg 2000;92:191–6.
54. Jahng TA, Fu TS, Cunningham BW, et al. Endoscopic instrumented posterolateral lumbar fusion with Healos and recombinant human growth/differentiation factor-5. Neurosurgery 2004;54:171–80; discussion 80–1.
55. Sangadala S, Boden SD, Viggeswarapu M, et al. LIM mineralization protein-1 potentiates bone morphogenetic protein responsiveness via a novel interaction with Smurf1 resulting in decreased ubiquitination of Smads. J Biol Chem 2006;281:17212–9.
56. Boden SD, Titus L, Hair G, et al. Lumbar spine fusion by local gene therapy with a cDNA encoding a novel osteoinductive protein (LMP-1). Spine 1998;23:2486–92.
57. Ludwig SC, Boden SD. Osteoinductive bone graft substitutes for spinal fusion: a basic science summary. Orthop Clin North Am 1999;30:635–45.
58. Burwell RG. The function of bone marrow in the incorporation of a bone graft. Clin Orthop Relat Res 1985;200:125–41.
59. Curylo LJ, Johnstone B, Petersilge CA, et al. Augmentation of spinal arthrodesis with autologous bone marrow in a rabbit posterolateral spine fusion model. Spine 1999;24:434–8; discussion 8–9.
60. Muschler GF, Matsukura Y, Nitto H, et al. Selective retention of bone marrow-derived cells to enhance spinal fusion. Clin Orthop Relat Res 2005;432:242–51.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Simpson, A.K., Whang, P.G., Grauer, J.N. (2008). Biological Approaches to Spinal Fusion. In: Pietrzak, W.S. (eds) Musculoskeletal Tissue Regeneration. Orthopedic Biology and Medicine. Humana Press. https://doi.org/10.1007/978-1-59745-239-7_12
Download citation
DOI: https://doi.org/10.1007/978-1-59745-239-7_12
Publisher Name: Humana Press
Print ISBN: 978-1-58829-909-3
Online ISBN: 978-1-59745-239-7
eBook Packages: MedicineMedicine (R0)